Hijacking the Hedgehog Pathway in Cancer Therapy

Author(s): Mikko O. Laukkanen, Maria Domenica Castellone

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 16 , Issue 3 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The hedgehog (Hh) signaling pathway, which is almost completely silenced in normal adult tissues but highly activated in cancer, offers ideal drug targets for small molecule development. During the last few years, several studies have indicated that the Hh pathway plays a role in tumor development and maintenance, and novel drugs inhibiting Hh signaling have been discovered. Although results from clinical trials in patients harboring activating mutations of Hh have been promising, there are many controversies regarding the role of the pathway in tumors that demonstrate ligand over-expression without identified mutations. In this review, we focus on the function and expression of the Hh pathway in different tumors and discuss the targeting approaches tested in preclinical and clinical studies.

Keywords: Cancer, hedgehog pathway, target therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [309 - 317]
Pages: 9
DOI: 10.2174/1871520615666151007160439
Price: $65

Article Metrics

PDF: 161
PRC: 1